Eagle Pharmaceuticals, Inc.
NASDAQ:EGRX
4.31 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 55.321 | 97.659 | 103.155 | 109.775 | 78.791 | 114.657 | 52.82 | 79.083 | 22.722 | 10.456 | 5.067 |
| Short Term Investments
| 0 | 4.983 | 0 | 0 | 0 | 0 | 0 | 0 | 19.999 | 0 | 1.5 |
| Cash and Short Term Investments
| 55.321 | 97.659 | 103.155 | 109.775 | 78.791 | 114.657 | 52.82 | 79.083 | 42.721 | 10.456 | 6.567 |
| Net Receivables
| 72.439 | 41.149 | 51.117 | 48.004 | 66.486 | 53.821 | 42.194 | 26.267 | 7.296 | 5.124 | 1.581 |
| Inventory
| 47.794 | 21.908 | 8.075 | 6.566 | 8.304 | 5.118 | 2.739 | 15.042 | 1.294 | 1.871 | 0.087 |
| Other Current Assets
| 13.2 | 11.89 | 1.605 | 15.104 | 10.263 | 15.101 | 11.357 | 1.865 | 1.711 | 0.032 | 0.138 |
| Total Current Assets
| 188.754 | 172.606 | 166.065 | 179.449 | 163.844 | 188.697 | 109.11 | 122.257 | 53.022 | 17.482 | 8.865 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 1.168 | 1.636 | 2.077 | 2.202 | 2.397 | 6.82 | 3.316 | 2.205 | 0.344 | 0.402 | 0.497 |
| Goodwill
| 45.033 | 39.743 | 39.743 | 39.743 | 39.743 | 39.743 | 39.743 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 118.327 | 10.671 | 12.917 | 15.583 | 18.103 | 23.322 | 32.622 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 163.36 | 50.414 | 52.66 | 55.326 | 57.846 | 63.065 | 72.365 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 10.011 | 6.03 | 12.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 27.146 | 18.798 | 15.18 | 13.669 | 13.822 | 11.354 | 28.643 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 15.721 | 4.248 | 5.008 | 3.908 | 0.694 | 0.124 | 0.136 | 0.143 | 0.045 | 0.218 | 0.076 |
| Total Non-Current Assets
| 217.406 | 81.126 | 87.125 | 75.105 | 74.759 | 81.363 | 104.46 | 2.348 | 0.389 | 0.62 | 0.573 |
| Total Assets
| 406.16 | 253.732 | 253.19 | 254.554 | 238.603 | 270.06 | 213.57 | 124.605 | 53.411 | 18.103 | 9.438 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 18.993 | 16.431 | 6.268 | 5.462 | 9.917 | 11.981 | 14.716 | 3.943 | 4.059 | 1.193 | 1.444 |
| Short Term Debt
| 6.25 | 25.607 | 8 | 5 | 6.25 | 4.875 | 0 | -0.086 | 9.226 | 3.06 | 8.572 |
| Tax Payables
| 5.182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 25.363 | 20.742 | 26.063 | 21.71 | 15.391 | 0 | 6 | 6.585 | 10.02 | 9.5 |
| Other Current Liabilities
| 85.844 | 6.975 | 3.075 | 2.298 | 1.809 | 15.055 | 25.499 | 24.405 | 0.445 | 0.069 | 1.366 |
| Total Current Liabilities
| 111.087 | 74.376 | 38.085 | 38.823 | 39.686 | 47.302 | 40.215 | 34.262 | 20.315 | 14.342 | 20.882 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 56.216 | 2.904 | 29.094 | 33.557 | 38.155 | 42.905 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | -1.751 | -5.892 | -1.084 | 0 | -3.05 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 1.751 | 1.933 | 1.084 | 0.687 | 3.05 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 5.297 | -0.001 | 3.959 | 3 | -0.687 | 0.709 | 22.129 | 0 | 0 | 1.707 | 0.655 |
| Total Non-Current Liabilities
| 61.513 | 2.903 | 29.094 | 36.557 | 38.155 | 43.614 | 22.129 | 9.857 | 10.644 | 1.707 | 0.655 |
| Total Liabilities
| 172.6 | 77.279 | 67.179 | 75.38 | 77.841 | 90.916 | 62.344 | 34.262 | 20.315 | 16.049 | 21.536 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 89.983 | 81.336 |
| Common Stock
| 0.018 | 0.017 | 0.017 | 0.017 | 0.017 | 0.016 | 0.016 | 0.015 | 0.014 | 0.003 | 0.002 |
| Retained Earnings
| 111.504 | 75.862 | 84.489 | 72.5 | 58.187 | 26.284 | -25.659 | -107.112 | -104.177 | -102.136 | -95.537 |
| Accumulated Other Comprehensive Income/Loss
| -1.112 | -0.094 | -0 | 0 | -0 | 0 | -0 | 0 | 0 | -89.983 | -81.336 |
| Other Total Stockholders Equity
| 123.15 | 100.668 | 101.505 | 106.657 | 102.558 | 152.844 | 176.869 | 197.44 | 137.259 | 104.187 | 83.438 |
| Total Shareholders Equity
| 233.56 | 176.453 | 186.011 | 179.174 | 160.762 | 179.144 | 151.226 | 90.343 | 33.096 | 2.054 | -12.098 |
| Total Equity
| 233.56 | 176.453 | 186.011 | 179.174 | 160.762 | 179.144 | 151.226 | 90.343 | 33.096 | 2.054 | -12.098 |
| Total Liabilities & Shareholders Equity
| 406.16 | 253.732 | 253.19 | 254.554 | 238.603 | 270.06 | 213.57 | 124.605 | 53.411 | 18.103 | 9.438 |